Nuclear FGFR2 was recently found to negatively regulate hypoxia-induced cell invasion in prostate cancer [187] and nuclear FGFR1 was positively corelated with pancreatic and breast cancer progression [178,179]. The gene discussed is FGFR1; the disease is prostate carcinoma.